Chester County News and Community Website
TELA Bio, Inc. (Nasdaq: TELA), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) will report its first-quarter 2026 financial results on Tuesday, May 12, 2026, and will host a conference call and webcast at 4:30 …
TELA Bio Schedules Q1 2026 Earnings Release and Call Read More MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) said it will report financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, March 24, 2026.
TELA Bio to Report Fourth Quarter and Full-Year 2025 Results March 24 Read More MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) announced that its board’s Compensation Committee approved inducement grants of restricted stock units covering 8,550 shares of common stock to three newly …
TELA Bio Grants Inducement RSUs to New Employees Read More MALVERN, PA — TELA Bio (NASDAQ: TELA) has approved inducement equity awards for five newly hired employees, signaling continued investment in talent as the medical technology company advances its commercial-stage …
TELA Bio Grants Equity to New Hires as Medtech Growth Push Continues Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has issued equity awards to newly hired staff, a move that reflects continued investment in talent as the medical technology company advances …
TELA Bio Signals Growth With New-Hire Equity Grants Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) will present its latest advances in soft-tissue reconstruction at Piper Sandler’s 37th Annual Healthcare Conference, the company announced, marking another opportunity for …
TELA Bio Set to Spotlight Soft-Tissue Innovations at Major Healthcare Conference Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced a new round of equity awards designed to attract and retain talent as the commercial-stage medtech firm expands its workforce and …
TELA Bio Unveils New Wave of Hiring With Stock Grants Tied to Growth Push Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) reported continued revenue growth and operational progress in the third quarter of 2025, supported by a strengthened leadership team, expanded sales infrastructure, …
TELA Bio Posts Steady Growth as Strategic Shift Sparks New Commercial Momentum Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced it will release its third-quarter 2025 financial results on Thursday, November 13, 2025, followed by a conference call and webcast at …
TELA Bio to Announce Q3 2025 Results, Host Investor Call November 13 Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced the appointment of William “Bill” Plovanic, CFA, to its Board of Directors, bringing more than 25 years of experience in capital …
TELA Bio Adds Veteran MedTech Executive Bill Plovanic to Board of Directors Read More